Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia

被引:22
作者
Rashed, MS
Al-Ahaidib, LY
Al-Dirbashi, OY
Al Amoudi, M
Al-Sayed, MMA
Rahbeeni, Z
Al-Hassnan, Z
Al-Dbaas, A
Luanaigh, MN
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia
[3] King Saud Univ, Coll Sci, Dept Biochem, Med Studies & Sci Sect, Riyadh 11495, Saudi Arabia
关键词
tyrosinemia; succinylacetone; LC-; MS/MS;
D O I
10.1016/j.ab.2005.01.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We describe ail isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination f succinylacetone (SA) in urine for the diagnosis of hepatorenal tyrosinernia (HT1). The method used N-15-labeled 5(3)-nicthyl-3(5)-isoxazole propionic acid as internal standard. Urine samples were oximated with hydroxylamine hydrochloride at 80 degrees C. extracted by solvent-solvent extraction, and followed by derivatization of the butyl ester. The butylated isoxazole derivatives of SA and its internal standard were detected and quantified using positive ion electrospray LC-MS/MS with selected reaction monitoring. The turnaround time between injections was 10 min. Calibration curves were linear over the range of 0.0633-63.3 mu mol/L. The intra- and interday assay variations were less than 7%. Mean recoveries of SA at three different concentrations ranged from 96 to 109%. During the Course of this Study, we identified 12 new patients with HT1 and applied this method to follow up the treatment of 4 of these patients as well as previously diagnosed HT1 patients. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 26 条
[1]   Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots [J].
Allard, P ;
Grenier, A ;
Korson, MS ;
Zytkovicz, TH .
CLINICAL BIOCHEMISTRY, 2004, 37 (11) :1010-1015
[2]   DEFICIENCY OF FUMARYLACETOACETASE IN A PATIENT WITH HEREDITARY TYROSINEMIA [J].
BERGER, R ;
SMIT, GPA ;
STOKERDEVRIES, SA ;
DURAN, M ;
KETTING, D ;
WADMAN, SK .
CLINICA CHIMICA ACTA, 1981, 114 (01) :37-44
[3]   BIOCHEMICAL-STUDIES ON THE ENZYMATIC DEFICIENCIES IN HEREDITARY TYROSINEMIA [J].
BERGER, R ;
VANFAASSEN, H ;
SMITH, GPA .
CLINICA CHIMICA ACTA, 1983, 134 (1-2) :129-141
[4]  
DHALIMY M, 2002, MOL GENET METAB, V75, P38
[5]   TYROSINEMIA - AN INBORN ERROR OF TYROSINE METABOLISM WITH CIRRHOSIS OF LIVER AND MULTIPLE RENAL TUBULAR DEFECTS ( DE TONI-DEBRE-FANCONI SYNDROME ) [J].
GENTZ, J ;
JAGENBURG, R ;
ZETTERSTROEM, R .
JOURNAL OF PEDIATRICS, 1965, 66 (04) :670-+
[6]   DETECTION OF SUCCINYLACETONE AND THE USE OF ITS MEASUREMENT IN MASS-SCREENING FOR HEREDITARY TYROSINEMIA [J].
GRENIER, A ;
LESCAULT, A ;
LABERGE, C ;
GAGNE, R ;
MAMER, O .
CLINICA CHIMICA ACTA, 1982, 123 (1-2) :93-99
[7]  
HOLME E, 1998, J INHERIT METAB DIS, V5, P5
[8]  
Holme Elisabeth, 1995, Current Opinion in Pediatrics, V7, P726
[9]   STABLE ISOTOPE-DILUTION ANALYSIS OF SUCCINYLACETONE USING ELECTRON-CAPTURE NEGATIVE-ION MASS FRAGMENTOGRAPHY - AN ACCURATE APPROACH TO THE PRENATAL AND NEONATAL DIAGNOSIS OF HEREDITARY TYROSINEMIA TYPE-I [J].
JAKOBS, C ;
DORLAND, L ;
WIKKERINK, B ;
KOK, RM ;
DEJONG, APJM ;
WADMAN, SK .
CLINICA CHIMICA ACTA, 1988, 171 (2-3) :223-231
[10]   TRYOSINAEMIA TYPE-I - AN UPDATE [J].
KVITTINGEN, EA .
JOURNAL OF INHERITED METABOLIC DISEASE, 1991, 14 (04) :554-562